Results 101 to 110 of about 34,408 (308)

Recommendations for the management of GnRH‐ant for ovarian stimulation in the assistant reproductive process: Benefits and harms for different ovarian response population

Clinical and Public Health Guidelines, Volume 2, Issue 3, July 2025.
Abstract Introduction: Gonadotropin‐releasing hormone antagonists (GnRH‐ant) are commonly used during controlled ovarian stimulation (COS) in the in vitro fertilization (IVF) process to prevent premature luteinization and to ensure follicles mature synchronously.
Rong Li, Rui Yang, Junhao Yan, Yang Song, Yunxia Cao, Zijiang Chen, Chenchen Xu, Zhan Zhao, Yichun Guan, Fei Gong, Guimin Hao, Hefeng Huang, Li Jin, Fenghua Liu, Jiayin Liu, Xiaoyan Liang, Xiaolin La, Yun Sun, Xiaohong Wang, Yanwen Xu, Cuilian Zhang, Jie Qiao   +21 more
wiley   +1 more source

Two Cases of Acute Cholecystitis and Symptomatic Choledocholithiasis in Two Women Less than 40-Years-of-Age with Hormonal Intrauterine Devices

Case Reports in Gastrointestinal Medicine, 2018
Levonorgestrel uterine implants are accepted as a safe and efficacious method of contraception. One of the two major health side effects in a large controlled study of subcutaneous hormonal implants with levonorgestrel was a significant increase in ...
Helen M. Shields, Hasrat Sidhu
doaj   +1 more source

FIGO position statement on postpartum intrauterine devices (PPIUD)

International Journal of Gynecology &Obstetrics, Volume 169, Issue 3, Page 1127-1132, June 2025.
Abstract Postpartum contraception is a critical intervention to address the unmet need for family planning, which affects over 218 million women globally, predominantly in low‐ and middle‐income countries (LMICs). Immediate postpartum family planning (PPFP) offers a unique opportunity to provide contraception during a crucial health‐seeking encounter ...
Anita Makins, Azra Ahsan, Marium Waqas, Asha Kasliwal, for the FIGO Committee on Contraception, Asha Kasliwal, Azra Ahsan, Aparna Sridhar, Cuauhtemoc C. González, Wai‐cheung Lam, Silvia Bonsergent, Felix Momat, Helena K. Kallner, Sara Ooi, Nomi Fuchs‐Montgomery, Anita Makins, Monica Kerrigan, Ian Askew   +17 more
wiley   +1 more source

A viable caesarean scar pregnancy in a woman using a levonorgestrel-releasing intrauterine device [PDF]

, 2018
__Background:__ Although the levonorgestrel-releasing intrauterine device (LNG-IUD) is one of the most reliable methods of contraception, it is associated with an increased risk of ectopic pregnancy in case of unintended pregnancy. A rare form of ectopic
Bogers, H. (Hein), Duvekot, J.J. (Hans), Hitzerd, E. (Emilie), Kianmanesh Rad, N.A. (Noush)   +3 more
core   +2 more sources

Ultrasound‐guided cyst aspiration for management of acute adnexal torsion

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 6, Page 790-797, June 2025.
ABSTRACT Objective Ultrasound‐guided cyst aspiration is a potential treatment for acute adnexal torsion that can be performed in the outpatient setting, offering an alternative to emergency laparoscopic surgery. The objective of this study was to describe our initial experience with aspiration of acutely torted adnexal cysts.
L. Berg, N. Eagles, S. Kastora, J. Farren, J. Naftalin, D. Jurkovic   +5 more
wiley   +1 more source

Evaluation of Levonorgestrel Subdermal Implant as Long Term Reversible Contraceptive

Journal of Rawalpindi Medical College, 2018
Background: To study the reasons of acceptability, efficacy,short term and long term side effects of Levonorgestrel Subdermal implant as long term reversible contraceptive.
Taqdees Iftikhar, Jehan Ara, Humaira Arshad, Nadra Sultana   +3 more
doaj  

Individualization of approaches to managing patients during menopausal transition

Репродуктивная эндокринология, 2018
The global aging of the population leads to a significant increase in the demographic burden on society, puts a heavy burden on the economy and causes significant structural changes in the sphere of social security.
Т. Ф Татарчук, В. І. Пирогова, О. О. Єфіменко, О. В. Булавенко, І. М. Антонян, Г. Я. Пілягіна   +5 more
doaj   +1 more source

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant

Human Reproduction, 2016
STUDY QUESTION Is it possible to extend the use of the 3-year one-rod etonogestrel (ENG)-releasing subdermal contraceptive implant to 5 years? SUMMARY ANSWER The extended use of the one-rod ENG-releasing subdermal contraceptive implant showed 100 ...
Moazzam Ali, A. Akın, L. Bahamondes, V. Brache, N. Habib, S. Landoulsi, D. Hubacher   +6 more
semanticscholar   +1 more source

Will the world decrease births or increase deaths?—A review of ‘Reproductive Medicine’--E. Coutinho & P. Spinola Eds. 366p (1999) [PDF]

, 2016
I review this report of an old medical congress on reproductive medicine. Much has happened in the 17 years since its publication but the most urgent task of preventing further population growth has largely failed on a global scale. I try to bring it up
Starks, Michael
core  

Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time [PDF]

, 2009
peer reviewedBACKGROUND: The levonorgestrel-releasing intrauterine system (LNG-IUS) is an effective contraceptive and has many non-contraceptive health benefits. However, it is commonly associated with irregular endometrial bleeding.
Foidart, Jean-Michel, Frankenne, F., Galant, C., Labied, Soraya, Marbaix, E., Munaut, Carine, Nisolle, Michelle, Ravet, Stéphanie   +7 more
core   +1 more source